Adenoviral vectors for gene transfer and therapy

Publisher Website
Google Scholar
Abstract
Due to the very efficient nuclear entry mechanism of adenovirus and its low pathogenicity for humans, adenovirus‐based vectors have become gene delivery vehicles that are widely used for transduction of different cell types, especially for quiescent, differentiated cells, in basic research, in gene therapy applications, and in vaccine development. As an important basis for their use as gene medicine, adenoviral vectors can be produced in high titers, they can transduce cells in vivo with transgenes of more than 30 kb, and they do not integrate into the host cell genome. Recent advances in the development of adenoviral vectors have brought considerable progress on issues like target cell specificity and tropism modification, long‐term expression of the transgene, as well as immunogenicity and toxicity in vivo, and have suggested that the different generations of non‐replicative and replicative vectors available today will each suit best for certain applications. Copyright © 2004 John Wiley & Sons, Ltd.

This publication has 0 references indexed in Scilit: